Literature DB >> 19218784

Differential FGF ligands and FGF receptors expression pattern in frontal and parietal calvarial bones.

Natalina Quarto1, Bjorn Behr, Shuli Li, Michael T Longaker.   

Abstract

The mammalian skull vault consists mainly of 5 flat bones, the paired frontals and parietals, and the unpaired interparietal. All of these bones are formed by intramembranous ossification within a layer of mesenchyme, the skeletogenic membrane, located between the dermal mesenchyme and the meninges surrounding the brain. While the frontal bones are of neural crest in origin, the parietal bones arise from mesoderm. The present study is a characterization of frontal and parietal bones at their molecular level, aiming to highlight distinct differences between the neural crest-derived frontal and mesodermal-derived parietal bone. We performed a detailed comparative gene expression profile of FGF ligands and their receptors known to play crucial role in skeletogenesis. This analysis revealed that a differential expression pattern of the major FGF osteogenic molecules and their receptors exists between the neural crest-derived frontal bone and the paraxial mesoderm-derived parietal bone. Particularly, the expression of ligands such as Fgf-2, Fgf-9 and Fgf-18 was upregulated in frontal bone on embryonic day 17.5, postnatal day 1 and postnatal day 60 mice. Frontal bone also elaborated higher levels of Fgf receptor 1, 2 and 3 transcripts versus parietal bone. Taken together, these data suggest that the frontal bone is a domain with higher FGF-signaling competence than parietal bone. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19218784      PMCID: PMC2820336          DOI: 10.1159/000202789

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  26 in total

Review 1.  Derivation of the mammalian skull vault.

Authors:  G M Morriss-Kay
Journal:  J Anat       Date:  2001 Jul-Aug       Impact factor: 2.610

Review 2.  Reaching a genetic and molecular understanding of skeletal development.

Authors:  Gerard Karsenty; Erwin F Wagner
Journal:  Dev Cell       Date:  2002-04       Impact factor: 12.270

Review 3.  FGF signaling in skeletal development.

Authors:  M C Naski; D M Ornitz
Journal:  Front Biosci       Date:  1998-08-01

4.  The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2.

Authors:  Hyun-Jung Kim; Jung-Hwan Kim; Suk-Chul Bae; Je-Yong Choi; Hyun-Jung Kim; Hyun-Mo Ryoo
Journal:  J Biol Chem       Date:  2002-10-25       Impact factor: 5.157

5.  FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis.

Authors:  Norihiko Ohbayashi; Masaki Shibayama; Yoko Kurotaki; Mayumi Imanishi; Toshihiko Fujimori; Nobuyuki Itoh; Shinji Takada
Journal:  Genes Dev       Date:  2002-04-01       Impact factor: 11.361

6.  Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18.

Authors:  Zhonghao Liu; Jingsong Xu; Jennifer S Colvin; David M Ornitz
Journal:  Genes Dev       Date:  2002-04-01       Impact factor: 11.361

7.  Fgfr mRNA isoforms in craniofacial bone development.

Authors:  D P C Rice; R Rice; I Thesleff
Journal:  Bone       Date:  2003-07       Impact factor: 4.398

Review 8.  Fibroblast growth factor signaling controlling osteoblast differentiation.

Authors:  P J Marie
Journal:  Gene       Date:  2003-10-16       Impact factor: 3.688

9.  FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod.

Authors:  Irene H Hung; Kai Yu; Kory J Lavine; David M Ornitz
Journal:  Dev Biol       Date:  2007-05-06       Impact factor: 3.582

10.  The IIIc alternative of Fgfr2 is a positive regulator of bone formation.

Authors:  Vereragavan P Eswarakumar; Efrat Monsonego-Ornan; Mark Pines; Ileana Antonopoulou; Gillian M Morriss-Kay; Peter Lonai
Journal:  Development       Date:  2002-08       Impact factor: 6.868

View more
  25 in total

1.  Opposite spectrum of activity of canonical Wnt signaling in the osteogenic context of undifferentiated and differentiated mesenchymal cells: implications for tissue engineering.

Authors:  Natalina Quarto; Björn Behr; Michael T Longaker
Journal:  Tissue Eng Part A       Date:  2010-10       Impact factor: 3.845

2.  Surveillance of Stem Cell Fate and Function: A System for Assessing Cell Survival and Collagen Expression In Situ.

Authors:  Graham G Walmsley; Kshemendra Senarath-Yapa; Taylor L Wearda; Siddharth Menon; Michael S Hu; Dominik Duscher; Zeshaan N Maan; Jonathan M Tsai; Elizabeth R Zielins; Irving L Weissman; Geoffrey C Gurtner; H Peter Lorenz; Michael T Longaker
Journal:  Tissue Eng Part A       Date:  2015-12-24       Impact factor: 3.845

3.  Bone vs. fat: embryonic origin of progenitors determines response to androgen in adipocytes and osteoblasts.

Authors:  Kristine M Wiren; Joel G Hashimoto; Anthony A Semirale; Xiao-Wei Zhang
Journal:  Bone       Date:  2011-06-17       Impact factor: 4.398

4.  Fgf-9 is required for angiogenesis and osteogenesis in long bone repair.

Authors:  Björn Behr; Philipp Leucht; Michael T Longaker; Natalina Quarto
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

Review 5.  Gene regulatory network from cranial neural crest cells to osteoblast differentiation and calvarial bone development.

Authors:  Junguang Liao; Yuping Huang; Qiang Wang; Sisi Chen; Chenyang Zhang; Dan Wang; Zhengbing Lv; Xingen Zhang; Mengrui Wu; Guiqian Chen
Journal:  Cell Mol Life Sci       Date:  2022-02-27       Impact factor: 9.261

6.  Effects of growth hormone on the ontogenetic allometry of craniofacial bones.

Authors:  Paula N Gonzalez; Erika Kristensen; Douglas W Morck; Steven Boyd; Benedikt Hallgrímsson
Journal:  Evol Dev       Date:  2013 Mar-Apr       Impact factor: 1.930

7.  Activation of FGF signaling mediates proliferative and osteogenic differences between neural crest derived frontal and mesoderm parietal derived bone.

Authors:  Shuli Li; Natalina Quarto; Michael T Longaker
Journal:  PLoS One       Date:  2010-11-18       Impact factor: 3.240

8.  Further analysis of the Crouzon mouse: effects of the FGFR2(C342Y) mutation are cranial bone-dependent.

Authors:  Jin Liu; Hwa Kyung Nam; Estee Wang; Nan E Hatch
Journal:  Calcif Tissue Int       Date:  2013-01-29       Impact factor: 4.333

9.  Integration of multiple signaling pathways determines differences in the osteogenic potential and tissue regeneration of neural crest-derived and mesoderm-derived calvarial bones.

Authors:  Kshemendra Senarath-Yapa; Shuli Li; Nathaniel P Meyer; Michael T Longaker; Natalina Quarto
Journal:  Int J Mol Sci       Date:  2013-03-15       Impact factor: 5.923

10.  Small Molecule Inhibition of Transforming Growth Factor Beta Signaling Enables the Endogenous Regenerative Potential of the Mammalian Calvarium.

Authors:  Kshemendra Senarath-Yapa; Shuli Li; Graham G Walmsley; Elizabeth Zielins; Kevin Paik; Jonathan A Britto; Agamemnon E Grigoriadis; Derrick C Wan; Karen J Liu; Michael T Longaker; Natalina Quarto
Journal:  Tissue Eng Part A       Date:  2016-04-26       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.